Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Presti

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Nature Clinical Practice. Urology|March 28, 2008
Does the yield of prostate cancer biopsy and repeat biopsy justify the frequency of their use?Joseph Presti
Current Urology Reports|September 4, 2008
The use of prostate-specific antigen kinetics to stratify risk in prostate cancerJoseph Presti
Journal of General Internal Medicine|July 14, 2021
Impact of 2012 Prostate Cancer Screening StatementJoseph Presti, Stacey Alexeeff, Andrew L Avins
The New England Journal of Medicine|July 5, 2023
Screening for Prostate CancerJoseph Presti, Stacey Alexeeff, Andrew L Avins
Urology|July 3, 2003
Cavoatrial tumor thrombus excision without circulatory arrestRajesh Shinghal, Luca A Vricella, R Scott Mitchell, et al.
Urology Practice|May 5, 2023
Reply by AuthorsBrandon Horton, Stacey Alexeeff, Stephanie Prausnitz, et al.
Journal of General Internal Medicine|October 27, 2020
Changing Provider PSA Screening Behavior Using Best Practice Advisories: Interventional Study in a Multispecialty Group PracticeJoseph Presti, Stacey Alexeeff, Brandon Horton, et al.
Journal of General Internal Medicine|December 11, 2019
Changes in Prostate Cancer Presentation Following the 2012 USPSTF Screening Statement: Observational Study in a Multispecialty Group PracticeJoseph Presti, Stacey Alexeeff, Brandon Horton, et al.
Urologic Oncology|June 16, 2020
Prospective development of a prostate cancer risk calculator in a racially diverse population: The Kaiser Permanente Prostate Cancer Risk CalculatorJoseph Presti, Stacey Alexeeff, Brandon Horton, et al.
Urology Practice|June 24, 2024
Reply by AuthorsJoseph Presti, Brandon Horton, Stacey Alexeeff, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Nature Clinical Practice. Urology|March 28, 2008
Does the yield of prostate cancer biopsy and repeat biopsy justify the frequency of their use?Joseph Presti
Current Urology Reports|September 4, 2008
The use of prostate-specific antigen kinetics to stratify risk in prostate cancerJoseph Presti
Journal of General Internal Medicine|July 14, 2021
Impact of 2012 Prostate Cancer Screening StatementJoseph Presti, Stacey Alexeeff, Andrew L Avins
The New England Journal of Medicine|July 5, 2023
Screening for Prostate CancerJoseph Presti, Stacey Alexeeff, Andrew L Avins
Urology|July 3, 2003
Cavoatrial tumor thrombus excision without circulatory arrestRajesh Shinghal, Luca A Vricella, R Scott Mitchell, et al.
Urology Practice|May 5, 2023
Reply by AuthorsBrandon Horton, Stacey Alexeeff, Stephanie Prausnitz, et al.
Journal of General Internal Medicine|October 27, 2020
Changing Provider PSA Screening Behavior Using Best Practice Advisories: Interventional Study in a Multispecialty Group PracticeJoseph Presti, Stacey Alexeeff, Brandon Horton, et al.
Journal of General Internal Medicine|December 11, 2019
Changes in Prostate Cancer Presentation Following the 2012 USPSTF Screening Statement: Observational Study in a Multispecialty Group PracticeJoseph Presti, Stacey Alexeeff, Brandon Horton, et al.
Urologic Oncology|June 16, 2020
Prospective development of a prostate cancer risk calculator in a racially diverse population: The Kaiser Permanente Prostate Cancer Risk CalculatorJoseph Presti, Stacey Alexeeff, Brandon Horton, et al.
Urology Practice|June 24, 2024
Reply by AuthorsJoseph Presti, Brandon Horton, Stacey Alexeeff, et al.
Pageof 2